Literature DB >> 8101045

Topics in clinical pharmacology: flumazenil, a benzodiazepine antagonist.

A W Longmire1, D L Seger.   

Abstract

Flumazenil is a central antagonist of the sedative effects of benzodiazepines. It has been used to reverse benzodiazepine effects in conscious sedation, general anesthesia, and overdose with restoration of alertness and psychomotor function within minutes of administration. Seizures have followed the use of flumazenil. Overdose patients who have co-ingested cyclic antidepressants are especially at risk for this complication. Flumazenil is administered intravenously in small, incremental doses.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101045     DOI: 10.1097/00000441-199307000-00012

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  2 in total

1.  A Pharmacokinetic-Pharmacodynamic Study of Intravenous Midazolam and Flumazenil in Adult New Zealand White-Californian Rabbits (Oryctolagus cuniculus).

Authors:  Frédérik Rousseau-Blass; Alastair E Cribb; Francis Beaudry; Daniel Sj Pang
Journal:  J Am Assoc Lab Anim Sci       Date:  2021-03-05       Impact factor: 1.232

Review 2.  Sleep-enhancing Effects of Phytoncide Via Behavioral, Electrophysiological, and Molecular Modeling Approaches.

Authors:  Junsung Woo; C Justin Lee
Journal:  Exp Neurobiol       Date:  2020-04-30       Impact factor: 3.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.